Dan, it is evident that no healthcare system would carry the burden of their device cost of therapy, considering their inadequate cost-effectiveness results and other associated factors, which hindered any potential future prospects. To support this assertion, I would like to refer you to the following link, which provides evidence of their subpar cost-effectiveness
News 
Market Data 
Discover 
